Skip to main content

Table 1 Clinical characteristics at hospital admission of COVID-19 dying individuals according to sex

From: Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy

  Overall (n = 3517) Women (n = 1171) Men (n = 2346) p value
Age, years (mean ± SD) 77.64 ± 11.51 80.40 ± 11.41 76.26 ± 11.32 < 0.001
Age tertiles, n (%)
 1° (age < 75 years) 1210 (34.4) 300 (25.6) 910 (38.8) < 0.001
 2° (75–84 years) 1285 (36.5) 383 (32.7) 902 (38.4)
 3° (> 84 years) 1022 (29.1) 488 (41.7) 534 (22.8)
Area of COVID-19 diffusion, n (%)b
 High 2547 (72.6) 826 (70.8) 1721 (73.5) 0.23
 Intermediate 790 (22.5) 279 (23.9) 511 (21.8)
 Low 172 (4.9) 62 (5.3) 110 (4.7)
Comorbidities, n (%)a
 Ischemic heart disease 957 (27.8) 236 (20.8) 721 (31.3) < 0.001
 Atrial fibrillation 758 (22.0) 260 (22.9) 498 (21.6) 0.43
 Congestive heart failure 539 (15.7) 209 (17.8) 330 (14.1) 0.002
 Stroke 349 (10.2) 118 (10.4) 231 (10.0) 0.76
 Hypertension 2305 (67.0) 774 (68.1) 1531 (66.5) 0.37
 Type-2 diabetes mellitus 1040 (30.3) 322 (28.3) 718 (31.2) 0.09
 Dementia 562 (16.3) 266 (23.4) 296 (12.9) < 0.001
 Chronic obstructive pulmonary disease 576 (16.8) 143 (12.6) 433 (18.8) < 0.001
 Active cancer 551 (16.0) 185 (16.3) 366 (15.9) 0.80
 Chronic liver disease 148 (4.3) 37 (3.3) 111 (4.8) 0.032
 Chronic renal disease 688 (20.0) 200 (17.6) 488 (21.2) 0.013
 Dialysis 67 (1.9) 19 (1.7) 48 (2.1) 0.43
 Respiratory failure 180 (5.2) 61 (5.4) 119 (5.2) 0.81
 HIV 7 (0.2) 0 (0.0) 7 (0.3) 0.10
 Autoimmune disease 137 (4.0) 67 (5.9) 70 (3.0) < 0.001
 Obesity 377 (11.0) 127 (11.2) 250 (10.9) 0.82
No. of comorbidities, n (%)
 0 144 (4.2) 33 (2.9) 111 (4.8) 0.54
 1 505 (14.7) 161 (14.2) 344 (15.0)
 2 738 (21.5) 250 (22.0) 488 (21.2)
 ≥ 3 2051 (59.6) 693 (60.9) 1358 (59.0)
  1. aMissing data for 79 patients (2.2%)
  2. bMissing data for 8 patients (0.2%)